UK drug update - August

1-Aug-2003

Roche has launched Fuzeon injection containing 90mg/ml of the fusion inhibitor enfuvirtide.

Viatris Pharmaceuticals has made available 300mg capsules of the NSAID etodolac under the trade name of Eccoxolac.

Beacon Pharmaceuticals has brought out chloroquine sulphate injection BP containing 200mg of the antimalarial drug chloroquine base in 5ml ampoules.

GlaxoSmithKline has made available a strawberry flavoured sugar-free suspension of Augmentin Duo 400/57 containing 400mg of the broad-spectrum penicillin amoxycillin and 57mg of the b-lactamase inhibitor clavulanic acid.

Alpharma has marketed 2mg, 5mg and 10mg tablets of the selective alpha1-blocker terazosin.

Forest Laboratories has introduced a 2 million unit vial presentation of Colomycin containing the antibiotic colistimethate sodium.

Pharmacia has launched Bextra tablets. The tablets contain 10mg, 20mg or 40mg of the cyclo-oxygenase-2 selective inhibitor valdecoxib.

PLIVA Pharma has made available a 2mg/ml intravenous infusion of the antifungal agent fluconazole.

Schering Health Care has marketed Testogel gel containing 50mg of the androgen testosterone in 5g gel.

Sign up for your free email newsletter

Galderma has brought out Metvix cream containing 160mg/g of the antineoplastic methyl aminolevulinate.

Companies